FIELD: medicine.
SUBSTANCE: invention is a pharmaceutical composition of active substances for an oral dosage form, in the form of a solid dosage form. The invention consists in being a bifunctional drug containing chondroitin sulfate, celecoxib as the biologically active substances and auxiliary substances as the rest, at a certain ratio of components.
EFFECT: creation of a drug for oral administration in the form of capsules, which has reparative, anti-inflammatory and analgesic effects and can be used as an independent or auxiliary drug for conditions associated with reduced functions of the musculoskeletal system.
3 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED ACTIVE COMPOSITION FOR TREATING LOCOMOTOR DISEASES | 2015 |
|
RU2582974C1 |
| EXTERNAL PREPARATION FOR TREATING ARTHROPATHIES AND SOFT TISSUE CONDITIONS | 2007 |
|
RU2377974C2 |
| METHOD FOR PRODUCING BIOLOGICALLY ACTIVE PHARMACEUTICAL SUBSTANCE FOR FEEDING EXTRACELLULAR MATRIX AND PREVENTING LOCOMOTOR DISEASES AND BARRIER FUNCTIONS OF RESPIRATORY AND DIGESTIVE ORGANS | 2019 |
|
RU2730477C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIULCEROGENIC ACTION, ABILITY TO INHIBIT DEVELOPMENT OF DEGENERATIVE-DESTRUCTIVE PROCESSES OF TISSUES, WHICH IS 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM-4-ISOBUTYLPHENYLPROPANOATE | 2023 |
|
RU2814495C1 |
| AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2260432C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY, CARDIO- AND CHONDROPROTECTIVE ACTIVITY, ACTION PREVENTING GASTROPATHIES CAUSED BY NSAID, AND METHOD FOR PREPARING IT | 2011 |
|
RU2502507C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING JOINT AND BONE TISSUE DISEASES | 2013 |
|
RU2547572C2 |
| METHOD OF TREATMENT OF JOINT DISEASES | 2022 |
|
RU2800537C1 |
| METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
| COMBINATION OF A CHONDROPROTECTIVE AGENT WITH AN NSAID | 2017 |
|
RU2742172C2 |
